Standout Papers

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EG... 2008 2026 2014 2020 654
  1. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations (2008)
    Lecia V. Sequist, Renato Martins et al. Journal of Clinical Oncology
  2. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (2017)
    Stephen Bagley, Shawn Kothari et al. Lung Cancer

Immediate Impact

25 from Science/Nature 74 standout
Sub-graph 1 of 18

Citing Papers

Extreme dynamics in a biomolecular condensate
2023 StandoutNature
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
2022 StandoutNature
2 intermediate papers

Works of Tracey L. Evans being referenced

Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response
2019
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
2017 Standout

Author Peers

Author Last Decade Papers Cites
Tracey L. Evans 2070 2057 212 920 103 3.9k
Michael Byrne 2081 1882 285 856 121 5.4k
Thierry Jahan 1739 1727 248 664 78 3.4k
James Stevenson 2748 3464 194 1183 136 5.7k
John W. Kugler 1375 2568 148 690 61 4.4k
Philip J. Stella 2094 3270 231 992 126 5.5k
Randolph S. Marks 2756 2647 176 1428 120 5.8k
Daniel Betticher 2195 2410 186 1669 154 5.3k
Tom Børge Johannesen 956 1990 206 639 85 3.5k
Jens Benn Sørensen 2380 1822 74 907 137 3.9k
Brett Hughes 2019 2224 85 801 174 4.2k

All Works

Loading papers...

Rankless by CCL
2026